Neuronetics
STIM
62 hedge funds and large institutions have $238M invested in Neuronetics in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 22 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 12
2.08% more ownership
Funds ownership: 69.13% → 71.21% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
16% less funds holding
Funds holding: 74 → 62 (-12)
38% less capital invested
Capital invested by funds: $383M → $238M (-$145M)
55% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$6.85M |
| 2 |
BlackRock
New York
|
+$4.48M |
| 3 |
FA
Friess Associates
Greenville,
Delaware
|
+$4.34M |
| 4 |
DM
Deerfield Management
New York
|
+$3.49M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$3.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$8.22M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$7.42M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$6.96M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$5.8M |
| 5 |
O
OrbiMed
New York
|
-$4.81M |
STIM Hedge Fund Activity: Q4 2018 in Review
62 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q4 2018, worth a combined $238M — down 38% from $383M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of STIM and 10 opened new positions — a net loss of 12 holders — while 12 trimmed existing stakes and 27 added.
The largest buyer was Capital Research Global Investors, adding an estimated $6.85M. The largest seller was Jennison Associates, exiting entirely with an estimated $8.22M sold.
- 62 institutional investors held Neuronetics (STIM) as of Q4 2018, down from 74 in Q3 2018.
- Funds reported $238M of Neuronetics stock for Q4 2018, down 38% quarter-over-quarter.
- 10 funds opened new Neuronetics positions in Q4 2018 and 22 closed out, a net change of -12 holders.
- The largest Neuronetics buyer in Q4 2018 was Capital Research Global Investors, an estimated $6.85M added.
- The largest Neuronetics seller in Q4 2018 was Jennison Associates, an estimated $8.22M sold.
Based on aggregated 13F filings for Q4 2018.